January 8, 2021 – Reno, NV, USA – Bio Health Solution is proud to announce the acceptance and publication of the AB070597 Human-Kidney Pilot Trial results by the Journal of Current Medical Research & Opinion.

Bio Health Solutions, a research and development company, is committed to development of high quality products that improve and extend the lives of humans and their companion animals; and holds United States and European patent assignments for AB070597, an amino acids and peptide complex, that maintains renal function homeostasis in mammalian kidneys. 

Mark Garrison, CEO of Bio Health Solutions stated:

“We are excited to announce that Bio Health Solutions’ intellectual property, AB070597, has now been shown to have a positive effect in the maintenance of normal human renal function. Former peer-reviewed scientific studies of AB070597’s efficacy in felines and canines have been the cornerstone for the grants of both US and EU patents. This recent accomplishment further bolsters our quest for an epigenetic solution in this most important worldwide healthcare crisis.”

The manuscript can be found at: http://cmro.in/index.php/jcmro/article/view/367

The Journal of Current Medical Research and Opinion aims to provide ethical, unbiased, and rapid publication of quality content that is validated by rigorous peer review. The Journal aims to serve the information needs of the clinical medicine community to help translate medical advances into patient care, lead in transparency, disclosure, and facilitate a collaborative and honest publication approach.

Media Contact
Company Name: Bio Health Solutions, Inc.
Contact Person: Victoria Shaver
Email: Send Email
Phone: 8005857187, ext.2
Country: United States
Website: biohealthsolutions.com